Lead: On March 15, 2026, a confidential federal work-group report prepared for the Advisory Committee on Immunization Practices (ACIP) recommended sweeping changes to how the medical system records and studies injuries attributed to Covid vaccines. The document — described by its authors as “written with a sense of urgency” — calls for a new diagnostic category, updated clinical guidelines and a coordinated research network to examine long-term harms. The proposals arrive amid a contested survey from 2023 and a June 2025 CDC briefing that found no increased risk of death after Covid vaccination. The report is confidential but has prompted debate among public-health bodies, clinicians and patient advocates.
Key Takeaways
- The confidential report, drafted for ACIP, urges creation of a distinct diagnostic category for Covid vaccine injuries and new clinical criteria to identify them.
- It recommends establishing a network of specialized research centers to study long-term neurological, cardiovascular and immune complaints allegedly linked to the vaccines.
- The report cites two polls, including a 2023 Rasmussen Reports survey of 1,110 U.S. adults that asked whether respondents knew someone who died from vaccine side effects; nearly one in four answered yes.
- The work group says thousands of people have reported a range of persistent symptoms after vaccination, many of whom feel dismissed by federal agencies.
- Federal surveillance systems cited by the CDC in June 2025 reported no detected increase in deaths following Covid vaccination.
- The American Academy of Pediatrics and other professional groups have challenged the report’s interpretation of existing evidence and some have taken legal action to limit ACIP’s meetings.
- If implemented, the proposals would change clinical coding, research funding priorities and how regulators review post‑vaccine signals.
Background
The debate over Covid vaccine safety remains politically and scientifically charged six years after the first shots were authorized. Hundreds of millions, and by some counts billions, of vaccine doses have been administered globally, and large-scale studies have generally found the vaccines to be safe for the vast majority of recipients. Still, a persistent minority of patients report new or worsening symptoms after vaccination and seek recognition and care.
Federal vaccine-safety monitoring in the United States relies on multiple systems — passive reporting tools, active safety surveillance and specialist committee review — and ACIP plays a key advisory role. In June 2025, Health Secretary Robert F. Kennedy Jr. reconstituted ACIP membership and the Centers for Disease Control and Prevention told the panel that its databases had not found an increased risk of death after Covid vaccination.
At the same time, advocacy groups and some researchers argue that current surveillance misses or misclassifies certain patterns of harm, especially complex, chronic conditions that are hard to link to a single exposure. The confidential work-group report responds to those concerns, arguing that existing frameworks are insufficient to capture and study a subset of reported post-vaccine conditions.
Main Event
The report, obtained and summarized publicly by news outlets, proposes three major reforms: a formal diagnostic category for suspected Covid vaccine injury, standardized diagnostic guidelines for clinicians, and a distributed network of research centers to study long-term outcomes. The authors say these steps would permit systematic data collection and better long-term follow-up of patients with persistent complaints.
According to the report, many people reporting problems describe neurological, cardiovascular or immune-system symptoms that began after vaccination. The work group contends that labeling some complaints as psychosomatic has discouraged care and research; it asks for protocols to distinguish post-vaccination syndromes from other conditions.
The report references two polls as evidence of public concern, including the Rasmussen Reports 2023 survey of 1,110 adults that asked whether respondents knew anyone who died from vaccine side effects. The work group does not equate self-reported narratives with verified causal links but treats them as a signal meriting deeper clinical and epidemiologic study.
Not all stakeholders accept the report’s assessment. Professional societies and some vaccine-safety experts say the document overstates the weight of anecdotal reports and underestimates robust surveillance results from the CDC and independent researchers. The tension prompted legal and public challenges to ACIP’s processes and membership earlier in 2026.
Analysis & Implications
If the recommendations are adopted, they would reshape both clinical practice and research priorities. A formal diagnostic code could make it easier for clinicians to document cases and for health systems to track outcomes; it could also affect insurance coverage and access to specialist care. Creating research centers would accelerate longitudinal studies but would require sustained funding and clear diagnostic criteria to produce interpretable results.
The proposal also has regulatory implications. Surveillance systems that rely on passive reporting can be overwhelmed by high-volume anecdote; conversely, active surveillance programs require predefined case definitions to estimate incidence. A new diagnostic category could reduce misclassification but risks creating new noise if applied inconsistently across providers.
Politically, the report arrives in a fraught environment. Health Secretary Robert F. Kennedy Jr.’s changes to ACIP and the prominence of a contested 2023 survey feed public skepticism and fuel advocacy. Policymakers will need to balance the legitimate need to investigate patient complaints with the risk of amplifying unverified claims that could undermine vaccine confidence.
Comparison & Data
| Item | Key data |
|---|---|
| Rasmussen “Killer Jab?” survey (2023) | 1,110 U.S. adults; nearly 1 in 4 reported knowing someone who died from vaccine side effects (self-reported) |
| CDC surveillance (June 2025) | Agency reported no detected increase in risk of death after Covid vaccination in its reviewed databases |
The table highlights a core tension: population surveys capture perceptions and personal networks, whereas public-health surveillance evaluates population-level risk signals. Both sources are informative but address different questions — perception and experience versus measured incidence. Any policy change should account for methodological differences and seek triangulation from multiple data streams.
Reactions & Quotes
“The report was written with a sense of urgency and urges systematic study of long-term symptoms some patients report after vaccination,”
Confidential federal work group report (summarized)
Context: The phrase reflects the document’s opening tone; the report frames its recommendations as responses to persistent patient complaints and gaps it perceives in current surveillance.
“We believe the document mischaracterizes the broader evidence on vaccine side effects,”
Dr. Sean O’Leary, American Academy of Pediatrics
Context: Dr. O’Leary and the American Academy of Pediatrics have argued the work group’s conclusions overstate anecdotal reports relative to population-based safety data; the academy is among organizations that have challenged department actions in court.
“Thousands of people say they were harmed and deserve careful clinical evaluation and study,”
Patient advocates (summary)
Context: Advocacy groups say dismissal of individual reports has left many without explanations or care pathways and that formal study could improve diagnosis and treatment.
Unconfirmed
- The claim that nearly one in four Americans know someone who died from a Covid vaccine comes from a 2023 Rasmussen survey of 1,110 adults; individual death reports cited by respondents are not independently verified in the survey.
- Specific case series or data quantifying the number of confirmed deaths causally linked to Covid vaccines are not provided in the confidential report and remain unproven.
- Details of the work group’s internal evidence review, including raw data and methods, have not been publicly released and could affect interpretation of its recommendations.
Bottom Line
The confidential work-group report spotlights a real policy dilemma: how to respond when many individuals report persistent health problems they attribute to a mass medical intervention, while large-scale surveillance finds no clear signal of increased mortality. The report’s practical proposals — new diagnostic coding, clinical guidelines and research centers — aim to improve case detection and follow-up but carry risks of misclassification and politicization.
Policymakers and public-health authorities should weigh the report’s recommendations against established surveillance findings, require transparent methods for any new diagnostic criteria, and ensure research networks are independently governed and adequately resourced. For clinicians and patients, the immediate need is better pathways for careful clinical evaluation, standardized data collection and rigorous long-term study to separate coincidence from causation.
Sources
- The New York Times (news report summarizing the confidential work-group report)
- Centers for Disease Control and Prevention (official federal agency — vaccine safety and ACIP information)
- Advisory Committee on Immunization Practices (ACIP) (official federal advisory committee — role and meeting materials)
- Rasmussen Reports (polling firm — source of the 2023 survey cited in the report)